Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-08

Clinical Trial Update: A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for LY3209590 in adults with Type 2 Diabetes Mellitus; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY3209590 (LY3209590)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2021-03-08